Issue: Volume VII No. 8 - May 30, 2000

Labs Should Leverage Their “Crown Jewels”

ONE NEW FEATURE of our annual Executive War College every May is a Lab CEO SUMMIT which takes place on the Thursday after the Tuesday-Wednesday event. It attracts a growing number of senior lab executives and pathologists who come to explore the strategic directions of the lab industry and pathology profession. This year’s Lab CEO …

Labs Should Leverage Their “Crown Jewels” Read More »

BRLI Ready To Leverage Physician Relationship

CEO SUMMARY: As healthcare E-commerce rapidly approaches, clinical laboratories will find they have a built-in competitive advantage—their existing business relationship and communication links to physician offices. Bio-Reference Laboratories, Inc. is moving rapidly to capitalize on this competitive advantage. It is making sizable investments to offer physicians more than just laboratory tests. IN THE COMING WORLD …

BRLI Ready To Leverage Physician Relationship Read More »

New CEO Takes Charge At Pathology Partners

CEO SUMMARY: Pathology Partners, Inc. got a new President and CEO this month. The company is organized to build and operate independent regional histology and cytology laboratories in support of anatomic pathologists. Its business model is different than competing pathology companies and Pathology Partners believes that it will be well-positioned as integrated clinical care becomes …

New CEO Takes Charge At Pathology Partners Read More »

War College Identifies Emerging Lab Trends

CEO SUMMARY: Disruptive technologies and the arrival of healthcare E-commerce were two common themes which emerged from this year’s Executive War College on Laboratory and Pathology Management. Consensus by faculty and attendees alike was that every lab organization should have an Internet business strategy, along with an accelerated implementation timetable! DESPITE CONTINUING laboratory consolidation and …

War College Identifies Emerging Lab Trends Read More »

Columbia/HCA’s $745 Mil Settlement Announced

CEO SUMMARY: Although Columbia/HCA will pay the feds $745 million as part of its recent settlement, the facts of “Medicare fraud” are far from convincing. Wall Street Journal analyst Holman W. Jenkins, Jr. makes a strong argument that the government was able to pick on Columbia/HCA for a variety of reasons, most tied to former …

Columbia/HCA’s $745 Mil Settlement Announced Read More »

Columbia/HCA, AmeriPath, Epitope, STC Technologies, Quest Diagnostics

COLUMBIA/HCA GETS NEW NAME; ACQUIRES FOUR LONDON HOSPITALS NOW THAT IT HAS A SETTLEMENT with the federal government on civil claims of Medicare fraud, expect a rapid cascade of changes at Columbia/HCA Healthcare Corporation, the nation’s largest for-profit hospital company. First is a new name. Effective on May 25, Columbia/HCA is now called HCA-The Healthcare …

Columbia/HCA, AmeriPath, Epitope, STC Technologies, Quest Diagnostics Read More »

“May 30, 2000 Intelligence: Late Breaking Lab News”

Expect an announcement this week that Pathology Consultants of America, Inc. (PCA), based in Nashville, Tennessee, has acquired PathSOURCE, Inc. of Port Chester, New York. Both are single specialty physician practice management (PPM) companies devoted exclusively to pathology. Each company has substantial venture capital funding. PathSOURCE, organized by dermatopathologists, did not generate the revenue growth …

“May 30, 2000 Intelligence: Late Breaking Lab News” Read More »